Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

被引：0
|
作者：
Rikke Hebo Larsen
Lisa Lyngsie Hjalgrim
Kathrine Grell
Kim Kristensen
Line Gerner Pedersen
Emilie Damgaard Brünner
Bodil Als-Nielsen
Kjeld Schmiegelow
Jacob Nersting
机构：
[1] University Hospital Rigshospitalet,Department of Pediatrics and Adolescent Medicine
[2] University of Copenhagen,Section of Biostatistics, Department of Public Health
[3] Novo Nordisk,Discovery and Development PKPD
[4] University of Copenhagen,Institute of Clinical Medicine, Faculty of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Childhood acute lymphoblastic leukemia; Leukemia; Cancer; Mercaptopurine; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 32
页数：7
相关论文
共 50 条
  • [41] CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - PHARMACOGENETIC VARIATION IN RESPONSE TO 6-MERCAPTOPURINE
    LENNARD, L
    LILLEYMAN, JS
    VANLOON, J
    WEINSHILBOUM, RM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : P324 - P324
  • [42] Severe Recurrent Nocturnal Hypoglycemia During Chemotherapy With 6-mercaptopurine in 2 Children With Acute Lymphoblastic Leukemia
    Albiroty, Khalil
    Al Sabahi, Amal
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (03) : 162 - 163
  • [43] PHARMACOKINETICS OF 6-MERCAPTOPURINE
    CALDERON, E
    TTERLIKKIS, LP
    SOLOMON, RB
    DAY, JL
    PHARMACOLOGIST, 1976, 18 (02): : 126 - 126
  • [44] USE OF ALLOPURINOL TO REDIRECT 6-MERCAPTOPURINE METABOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Stuckert, Austin
    Schafer, Eric
    Bernhardt, M. Brooke
    Baxter, Patricia
    Brackett, Julienne
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [45] PHARMACOKINETIC DETERMINANTS OF 6-MERCAPTOPURINE, MYELOTOXICITY AND THERAPEUTIC FAILURE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    WHALEN, CE
    SOLDIN, SJ
    SULH, H
    KOREN, G
    GREENBERG, M
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1092 - 1092
  • [46] ARE CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA RESISTANT TO 6-MERCAPTOPURINE BECAUSE OF 5'-NUCLEOTIDASE
    PIETERS, R
    HUISMANS, DR
    VEERMAN, AJP
    LANCET, 1987, 2 (8573): : 1471 - 1471
  • [47] 6-Mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia
    K Schmiegelow
    U Bretton-Meyer
    Leukemia, 2001, 15 : 74 - 79
  • [48] 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia
    Schmiegelow, K
    Bretton-Meyer, U
    LEUKEMIA, 2001, 15 (01) : 74 - 79
  • [49] PHARMACOKINETIC DETERMINANTS OF 6-MERCAPTOPURINE (6 MP) MYELOTOXICITY AND THERAPEUTIC FAILURES IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    KOREN, G
    SULH, H
    WHALEN, C
    SOLDIN, S
    ZIPURSKY, A
    GREENBERG, M
    PEDIATRIC RESEARCH, 1986, 20 (04) : A205 - A205
  • [50] 1112 6-Mercaptopurine Induced Symptomatic Hypoglycaemia in Children with Acute Lymphoblastic Leukaemia
    M White
    L Storey
    C Costigan
    O Smith
    Pediatric Research, 2010, 68 : 551 - 552
12345